nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Pain in jaw—Vincristine—muscle cancer	0.0444	0.0471	CcSEcCtD
Treprostinil—Induration—Etoposide—muscle cancer	0.0262	0.0278	CcSEcCtD
Treprostinil—Bone pain—Vincristine—muscle cancer	0.0151	0.016	CcSEcCtD
Treprostinil—Sepsis—Dactinomycin—muscle cancer	0.0141	0.0149	CcSEcCtD
Treprostinil—Cellulitis—Etoposide—muscle cancer	0.0129	0.0137	CcSEcCtD
Treprostinil—Hypoxia—Methotrexate—muscle cancer	0.0111	0.0117	CcSEcCtD
Treprostinil—Pain in extremity—Vincristine—muscle cancer	0.0105	0.0111	CcSEcCtD
Treprostinil—Sepsis—Etoposide—muscle cancer	0.0102	0.0108	CcSEcCtD
Treprostinil—Dehydration—Vincristine—muscle cancer	0.00977	0.0104	CcSEcCtD
Treprostinil—Cardiac failure congestive—Etoposide—muscle cancer	0.00938	0.00994	CcSEcCtD
Treprostinil—PPARD—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—muscle cancer	0.00935	0.166	CbGpPWpGaD
Treprostinil—Pneumonia—Dactinomycin—muscle cancer	0.00911	0.00966	CcSEcCtD
Treprostinil—Cardiac failure—Etoposide—muscle cancer	0.00872	0.00924	CcSEcCtD
Treprostinil—Haemoptysis—Doxorubicin—muscle cancer	0.00822	0.00871	CcSEcCtD
Treprostinil—Pneumonia—Vincristine—muscle cancer	0.00814	0.00863	CcSEcCtD
Treprostinil—Pharyngitis—Dactinomycin—muscle cancer	0.00807	0.00855	CcSEcCtD
Treprostinil—Depression—Vincristine—muscle cancer	0.00807	0.00855	CcSEcCtD
Treprostinil—Flushing—Dactinomycin—muscle cancer	0.00755	0.008	CcSEcCtD
Treprostinil—Erythema—Dactinomycin—muscle cancer	0.00708	0.0075	CcSEcCtD
Treprostinil—Pulmonary embolism—Methotrexate—muscle cancer	0.00702	0.00744	CcSEcCtD
Treprostinil—PTGIR—Small Ligand GPCRs—CNR1—muscle cancer	0.007	0.125	CbGpPWpGaD
Treprostinil—Melaena—Methotrexate—muscle cancer	0.00686	0.00727	CcSEcCtD
Treprostinil—Rectal haemorrhage—Doxorubicin—muscle cancer	0.00673	0.00713	CcSEcCtD
Treprostinil—Viral infection—Doxorubicin—muscle cancer	0.00673	0.00713	CcSEcCtD
Treprostinil—Cellulitis—Doxorubicin—muscle cancer	0.00669	0.00709	CcSEcCtD
Treprostinil—Pneumonia—Etoposide—muscle cancer	0.0066	0.00699	CcSEcCtD
Treprostinil—Ill-defined disorder—Dactinomycin—muscle cancer	0.00657	0.00696	CcSEcCtD
Treprostinil—Anaemia—Dactinomycin—muscle cancer	0.00655	0.00694	CcSEcCtD
Treprostinil—Malaise—Dactinomycin—muscle cancer	0.00639	0.00677	CcSEcCtD
Treprostinil—Ecchymosis—Methotrexate—muscle cancer	0.00635	0.00673	CcSEcCtD
Treprostinil—Bone pain—Doxorubicin—muscle cancer	0.00635	0.00673	CcSEcCtD
Treprostinil—Neck pain—Doxorubicin—muscle cancer	0.00616	0.00652	CcSEcCtD
Treprostinil—Back pain—Vincristine—muscle cancer	0.00612	0.00648	CcSEcCtD
Treprostinil—Sepsis—Methotrexate—muscle cancer	0.00609	0.00646	CcSEcCtD
Treprostinil—Pulmonary embolism—Doxorubicin—muscle cancer	0.00608	0.00644	CcSEcCtD
Treprostinil—Myalgia—Dactinomycin—muscle cancer	0.00603	0.00639	CcSEcCtD
Treprostinil—Discomfort—Dactinomycin—muscle cancer	0.00596	0.00631	CcSEcCtD
Treprostinil—Melaena—Doxorubicin—muscle cancer	0.00594	0.00629	CcSEcCtD
Treprostinil—Thrombophlebitis—Methotrexate—muscle cancer	0.00589	0.00624	CcSEcCtD
Treprostinil—Anaemia—Vincristine—muscle cancer	0.00585	0.0062	CcSEcCtD
Treprostinil—Oedema—Dactinomycin—muscle cancer	0.00578	0.00612	CcSEcCtD
Treprostinil—Infection—Dactinomycin—muscle cancer	0.00574	0.00608	CcSEcCtD
Treprostinil—Thrombocytopenia—Dactinomycin—muscle cancer	0.00566	0.006	CcSEcCtD
Treprostinil—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00559	0.00592	CcSEcCtD
Treprostinil—Anorexia—Dactinomycin—muscle cancer	0.00551	0.00584	CcSEcCtD
Treprostinil—Ecchymosis—Doxorubicin—muscle cancer	0.0055	0.00583	CcSEcCtD
Treprostinil—Flushing—Etoposide—muscle cancer	0.00546	0.00579	CcSEcCtD
Treprostinil—Myalgia—Vincristine—muscle cancer	0.00539	0.00571	CcSEcCtD
Treprostinil—Sepsis—Doxorubicin—muscle cancer	0.00528	0.00559	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00527	0.00558	CcSEcCtD
Treprostinil—Oedema—Vincristine—muscle cancer	0.00516	0.00547	CcSEcCtD
Treprostinil—Infection—Vincristine—muscle cancer	0.00513	0.00544	CcSEcCtD
Treprostinil—Thrombophlebitis—Doxorubicin—muscle cancer	0.0051	0.0054	CcSEcCtD
Treprostinil—Thrombocytopenia—Vincristine—muscle cancer	0.00506	0.00536	CcSEcCtD
Treprostinil—Decreased appetite—Dactinomycin—muscle cancer	0.00502	0.00532	CcSEcCtD
Treprostinil—Fatigue—Dactinomycin—muscle cancer	0.00498	0.00528	CcSEcCtD
Treprostinil—Back pain—Etoposide—muscle cancer	0.00496	0.00525	CcSEcCtD
Treprostinil—Pain—Dactinomycin—muscle cancer	0.00494	0.00524	CcSEcCtD
Treprostinil—Muscle spasms—Etoposide—muscle cancer	0.00493	0.00522	CcSEcCtD
Treprostinil—Anorexia—Vincristine—muscle cancer	0.00492	0.00522	CcSEcCtD
Treprostinil—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00487	0.00516	CcSEcCtD
Treprostinil—Hypotension—Vincristine—muscle cancer	0.00483	0.00511	CcSEcCtD
Treprostinil—Feeling abnormal—Dactinomycin—muscle cancer	0.00476	0.00505	CcSEcCtD
Treprostinil—Ill-defined disorder—Etoposide—muscle cancer	0.00476	0.00504	CcSEcCtD
Treprostinil—Anaemia—Etoposide—muscle cancer	0.00474	0.00502	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00473	0.00501	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0047	0.00498	CcSEcCtD
Treprostinil—Insomnia—Vincristine—muscle cancer	0.00467	0.00495	CcSEcCtD
Treprostinil—Paraesthesia—Vincristine—muscle cancer	0.00464	0.00491	CcSEcCtD
Treprostinil—Malaise—Etoposide—muscle cancer	0.00462	0.0049	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—muscle cancer	0.00457	0.00484	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—muscle cancer	0.00457	0.00484	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—muscle cancer	0.00452	0.00479	CcSEcCtD
Treprostinil—Loss of consciousness—Etoposide—muscle cancer	0.0045	0.00477	CcSEcCtD
Treprostinil—Decreased appetite—Vincristine—muscle cancer	0.00449	0.00476	CcSEcCtD
Treprostinil—Cough—Etoposide—muscle cancer	0.00447	0.00474	CcSEcCtD
Treprostinil—Fatigue—Vincristine—muscle cancer	0.00445	0.00472	CcSEcCtD
Treprostinil—Pain—Vincristine—muscle cancer	0.00442	0.00468	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—muscle cancer	0.00441	0.00468	CcSEcCtD
Treprostinil—Chest pain—Etoposide—muscle cancer	0.00436	0.00462	CcSEcCtD
Treprostinil—Discomfort—Etoposide—muscle cancer	0.00431	0.00457	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—PAX3—muscle cancer	0.00428	0.0762	CbGpPWpGaD
Treprostinil—Abdominal discomfort—Methotrexate—muscle cancer	0.00422	0.00448	CcSEcCtD
Treprostinil—Gastrointestinal pain—Vincristine—muscle cancer	0.00422	0.00447	CcSEcCtD
Treprostinil—Infection—Etoposide—muscle cancer	0.00416	0.0044	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—muscle cancer	0.00415	0.00439	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—muscle cancer	0.00411	0.00435	CcSEcCtD
Treprostinil—Thrombocytopenia—Etoposide—muscle cancer	0.0041	0.00434	CcSEcCtD
Treprostinil—Tachycardia—Etoposide—muscle cancer	0.00408	0.00433	CcSEcCtD
Treprostinil—Body temperature increased—Vincristine—muscle cancer	0.00408	0.00433	CcSEcCtD
Treprostinil—Abdominal pain—Vincristine—muscle cancer	0.00408	0.00433	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—muscle cancer	0.00402	0.00426	CcSEcCtD
Treprostinil—Anorexia—Etoposide—muscle cancer	0.00399	0.00422	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—muscle cancer	0.00395	0.00419	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—muscle cancer	0.00395	0.00419	CcSEcCtD
Treprostinil—Depression—Methotrexate—muscle cancer	0.00392	0.00415	CcSEcCtD
Treprostinil—Hypotension—Etoposide—muscle cancer	0.00391	0.00414	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—muscle cancer	0.00382	0.00404	CcSEcCtD
Treprostinil—Paraesthesia—Etoposide—muscle cancer	0.00376	0.00398	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—muscle cancer	0.00375	0.00397	CcSEcCtD
Treprostinil—Dyspnoea—Etoposide—muscle cancer	0.00373	0.00395	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—muscle cancer	0.00371	0.00393	CcSEcCtD
Treprostinil—Asthenia—Vincristine—muscle cancer	0.0037	0.00393	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—muscle cancer	0.00367	0.00389	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—muscle cancer	0.00367	0.00389	CcSEcCtD
Treprostinil—Rash—Dactinomycin—muscle cancer	0.00364	0.00386	CcSEcCtD
Treprostinil—Decreased appetite—Etoposide—muscle cancer	0.00364	0.00385	CcSEcCtD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.00363	0.0645	CbGpPWpGaD
Treprostinil—Fatigue—Etoposide—muscle cancer	0.00361	0.00382	CcSEcCtD
Treprostinil—Pain—Etoposide—muscle cancer	0.00358	0.00379	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—muscle cancer	0.00354	0.00376	CcSEcCtD
Treprostinil—Diarrhoea—Vincristine—muscle cancer	0.00353	0.00374	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—muscle cancer	0.00353	0.00374	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—muscle cancer	0.0035	0.00371	CcSEcCtD
Treprostinil—Feeling abnormal—Etoposide—muscle cancer	0.00345	0.00365	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—muscle cancer	0.00343	0.00364	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—muscle cancer	0.00342	0.00363	CcSEcCtD
Treprostinil—Gastrointestinal pain—Etoposide—muscle cancer	0.00342	0.00362	CcSEcCtD
Treprostinil—Dizziness—Vincristine—muscle cancer	0.00341	0.00362	CcSEcCtD
Treprostinil—Abdominal pain—Etoposide—muscle cancer	0.00331	0.0035	CcSEcCtD
Treprostinil—Body temperature increased—Etoposide—muscle cancer	0.00331	0.0035	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—muscle cancer	0.00331	0.0035	CcSEcCtD
Treprostinil—Vomiting—Vincristine—muscle cancer	0.00328	0.00348	CcSEcCtD
Treprostinil—Rash—Vincristine—muscle cancer	0.00326	0.00345	CcSEcCtD
Treprostinil—Dermatitis—Vincristine—muscle cancer	0.00325	0.00345	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—muscle cancer	0.00324	0.00344	CcSEcCtD
Treprostinil—Headache—Vincristine—muscle cancer	0.00323	0.00343	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—muscle cancer	0.00321	0.0034	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—muscle cancer	0.00319	0.00338	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—muscle cancer	0.00311	0.00329	CcSEcCtD
Treprostinil—Erythema—Methotrexate—muscle cancer	0.00307	0.00325	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—muscle cancer	0.00307	0.00325	CcSEcCtD
Treprostinil—Nausea—Vincristine—muscle cancer	0.00307	0.00325	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—muscle cancer	0.00306	0.00324	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—muscle cancer	0.00305	0.00324	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—muscle cancer	0.00303	0.00321	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—muscle cancer	0.00301	0.00319	CcSEcCtD
Treprostinil—Asthenia—Etoposide—muscle cancer	0.003	0.00318	CcSEcCtD
Treprostinil—Back pain—Methotrexate—muscle cancer	0.00297	0.00315	CcSEcCtD
Treprostinil—Pruritus—Etoposide—muscle cancer	0.00296	0.00314	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—muscle cancer	0.00286	0.00303	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—muscle cancer	0.00285	0.00302	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—muscle cancer	0.00284	0.00301	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—muscle cancer	0.00283	0.003	CcSEcCtD
Treprostinil—Malaise—Methotrexate—muscle cancer	0.00277	0.00293	CcSEcCtD
Treprostinil—Dizziness—Etoposide—muscle cancer	0.00277	0.00293	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—DMD—muscle cancer	0.00272	0.0484	CbGpPWpGaD
Treprostinil—Cough—Methotrexate—muscle cancer	0.00268	0.00284	CcSEcCtD
Treprostinil—Vomiting—Etoposide—muscle cancer	0.00266	0.00282	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—muscle cancer	0.00266	0.00282	CcSEcCtD
Treprostinil—Rash—Etoposide—muscle cancer	0.00264	0.00279	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—muscle cancer	0.00264	0.00279	CcSEcCtD
Treprostinil—Headache—Etoposide—muscle cancer	0.00262	0.00278	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—muscle cancer	0.00261	0.00277	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—muscle cancer	0.00261	0.00277	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—muscle cancer	0.00261	0.00277	CcSEcCtD
Treprostinil—Tension—Doxorubicin—muscle cancer	0.00261	0.00276	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—muscle cancer	0.00258	0.00274	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—muscle cancer	0.00258	0.00274	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—muscle cancer	0.00257	0.00272	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—muscle cancer	0.00256	0.00271	CcSEcCtD
Treprostinil—Infection—Methotrexate—muscle cancer	0.00249	0.00264	CcSEcCtD
Treprostinil—Nausea—Etoposide—muscle cancer	0.00248	0.00263	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—muscle cancer	0.00247	0.00261	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—muscle cancer	0.00246	0.0026	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—muscle cancer	0.00245	0.0026	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—muscle cancer	0.0024	0.00254	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—muscle cancer	0.00239	0.00253	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—muscle cancer	0.00238	0.00253	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—muscle cancer	0.00235	0.00249	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—muscle cancer	0.00234	0.00248	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—muscle cancer	0.00234	0.00248	CcSEcCtD
Treprostinil—Cough—Doxorubicin—muscle cancer	0.00232	0.00246	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00228	0.00242	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—muscle cancer	0.00227	0.0024	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—muscle cancer	0.00226	0.0024	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—muscle cancer	0.00226	0.0024	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—muscle cancer	0.00226	0.0024	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—muscle cancer	0.00226	0.00239	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—muscle cancer	0.00225	0.00238	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—muscle cancer	0.00224	0.00237	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—muscle cancer	0.00223	0.00237	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—muscle cancer	0.00221	0.00234	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—muscle cancer	0.00218	0.00231	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—muscle cancer	0.00217	0.0023	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—muscle cancer	0.00216	0.00229	CcSEcCtD
Treprostinil—Infection—Doxorubicin—muscle cancer	0.00216	0.00228	CcSEcCtD
Treprostinil—Pain—Methotrexate—muscle cancer	0.00214	0.00227	CcSEcCtD
Treprostinil—Shock—Doxorubicin—muscle cancer	0.00213	0.00226	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—muscle cancer	0.00212	0.00225	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—muscle cancer	0.00212	0.00224	CcSEcCtD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.00211	0.0376	CbGpPWpGaD
Treprostinil—Anorexia—Doxorubicin—muscle cancer	0.00207	0.00219	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—muscle cancer	0.00206	0.00219	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—muscle cancer	0.00205	0.00217	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—muscle cancer	0.00203	0.00215	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—muscle cancer	0.00198	0.0021	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—muscle cancer	0.00198	0.0021	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00198	0.00209	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—muscle cancer	0.00196	0.00208	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—muscle cancer	0.00195	0.00206	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—muscle cancer	0.00193	0.00205	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—muscle cancer	0.00191	0.00202	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—muscle cancer	0.00189	0.002	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—HMGA1—muscle cancer	0.00187	0.0333	CbGpPWpGaD
Treprostinil—Fatigue—Doxorubicin—muscle cancer	0.00187	0.00198	CcSEcCtD
Treprostinil—Pain—Doxorubicin—muscle cancer	0.00186	0.00197	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—muscle cancer	0.0018	0.0019	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—muscle cancer	0.00179	0.00189	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00177	0.00188	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—muscle cancer	0.00177	0.00188	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00174	0.031	CbGpPWpGaD
Treprostinil—Abdominal pain—Doxorubicin—muscle cancer	0.00172	0.00182	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—muscle cancer	0.00172	0.00182	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—muscle cancer	0.00171	0.00182	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—muscle cancer	0.00166	0.00176	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—muscle cancer	0.00159	0.00169	CcSEcCtD
Treprostinil—Rash—Methotrexate—muscle cancer	0.00158	0.00167	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—muscle cancer	0.00158	0.00167	CcSEcCtD
Treprostinil—Headache—Methotrexate—muscle cancer	0.00157	0.00166	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—muscle cancer	0.00156	0.00165	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—muscle cancer	0.00153	0.00163	CcSEcCtD
Treprostinil—Nausea—Methotrexate—muscle cancer	0.00149	0.00158	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—muscle cancer	0.00148	0.00157	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—muscle cancer	0.00143	0.00152	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—muscle cancer	0.00138	0.00146	CcSEcCtD
Treprostinil—Rash—Doxorubicin—muscle cancer	0.00137	0.00145	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—muscle cancer	0.00137	0.00145	CcSEcCtD
Treprostinil—Headache—Doxorubicin—muscle cancer	0.00136	0.00144	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—muscle cancer	0.00129	0.00137	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—FOXO1—muscle cancer	0.00124	0.0221	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CNR1—muscle cancer	0.00102	0.0181	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000944	0.0168	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ANGPT2—muscle cancer	0.000926	0.0165	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000873	0.0155	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000868	0.0154	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ANGPT2—muscle cancer	0.000852	0.0152	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MED12—muscle cancer	0.000826	0.0147	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000808	0.0144	CbGpPWpGaD
Treprostinil—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000766	0.0136	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000744	0.0132	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—PTCH1—muscle cancer	0.000729	0.013	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000694	0.0124	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—PTCH1—muscle cancer	0.000671	0.0119	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CNR1—muscle cancer	0.000616	0.011	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CNR1—muscle cancer	0.000567	0.0101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIDINS220—muscle cancer	0.000562	0.00999	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—FH—muscle cancer	0.000547	0.00973	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—muscle cancer	0.000519	0.00923	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIDINS220—muscle cancer	0.000517	0.0092	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF2—muscle cancer	0.00045	0.00801	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF2—muscle cancer	0.000414	0.00737	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MED12—muscle cancer	0.000398	0.00707	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTCH1—muscle cancer	0.000374	0.00666	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000366	0.00651	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CNR1—muscle cancer	0.000348	0.00619	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTCH1—muscle cancer	0.000344	0.00613	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CNR1—muscle cancer	0.00032	0.0057	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CNR1—muscle cancer	0.000316	0.00562	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00031	0.00552	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MED12—muscle cancer	0.000309	0.0055	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CNR1—muscle cancer	0.000291	0.00517	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO2—muscle cancer	0.000282	0.00501	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTCH1—muscle cancer	0.000221	0.00393	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.00022	0.00392	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTCH1—muscle cancer	0.000203	0.00362	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FOXO4—muscle cancer	0.00019	0.00338	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—muscle cancer	0.000189	0.00336	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CNR1—muscle cancer	0.000187	0.00332	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO4—muscle cancer	0.000175	0.00311	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—muscle cancer	0.000174	0.00309	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR1—muscle cancer	0.000172	0.00306	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—muscle cancer	0.000153	0.00271	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—muscle cancer	0.000143	0.00254	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—muscle cancer	0.00014	0.0025	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FOXO1—muscle cancer	0.00014	0.0025	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00014	0.00248	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—muscle cancer	0.000131	0.00234	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO1—muscle cancer	0.000129	0.0023	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FH—muscle cancer	0.00011	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—muscle cancer	0.000107	0.0019	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—muscle cancer	9.85e-05	0.00175	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—muscle cancer	9.82e-05	0.00175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MDM2—muscle cancer	8.43e-05	0.0015	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MDM2—muscle cancer	7.75e-05	0.00138	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—muscle cancer	6.4e-05	0.00114	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MED12—muscle cancer	6.22e-05	0.00111	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—muscle cancer	5.89e-05	0.00105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO2—muscle cancer	5.67e-05	0.00101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—muscle cancer	4.83e-05	0.00086	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—muscle cancer	4.45e-05	0.000792	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.43e-05	0.000789	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—muscle cancer	1.97e-05	0.000351	CbGpPWpGaD
